Balversa 4MG tabs
Ended Awarded Last action
- Contract number
- 36C25520N0322
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,091
Award facts
- Contract value 100% obligated
- $15,090.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Frisco, TX 75034, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $15,091 |
About this award
This is a federal contract award to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) awarded against Actelion's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The BPA has a ceiling value of $83.5 million and a one-year period of performance. It covers the procurement of Actelion's specialized medications for treating pulmonary arterial hypertension, including Tracleer, Zavesca, Ventavis, Opsumit, Uptravi, Veletri, and Opsynvi. These drugs are critical for providing care to veterans and other federal healthcare beneficiaries. The contract does not have a set-aside designation. Actelion has received numerous delivery orders against this BPA and its FSS contract to supply the VA and other federal agencies with these essential pharmaceutical products.
Quick answers
Who was awarded contract 36C25520N0322?
36C25520N0322 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on August 4, 2020.
How much is contract 36C25520N0322 worth?
The government has obligated $15,091 on 36C25520N0322.
Is contract 36C25520N0322 an order under another contract?
Yes. 36C25520N0322 is a BPA call under 36F79719D0142-36E79719A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25520N0322 competed?
The extent of competition for 36C25520N0322 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award